We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+2.75%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$27.5B
AUM Growth
+$4.26B
Cap. Flow
+$26B
Cap. Flow %
94.62%
Top 10 Hldgs %
8.07%
Holding
3,226
New
745
Increased
868
Reduced
662
Closed
894

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$151M
2
JNJ icon
Johnson & Johnson
JNJ
+$149M
3
COP icon
ConocoPhillips
COP
+$142M
4
DHR icon
Danaher
DHR
+$112M
5
SPGI icon
S&P Global
SPGI
+$106M

Sector Composition

Rank Sector Weight
1 Technology 21.09%
2 Consumer Discretionary 14.55%
3 Financials 12.04%
4 Healthcare 11.32%
5 Industrials 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOAT icon
2326
VanEck Morningstar Wide Moat ETF
MOAT
$11.9B
$122 ﹤0.01%
1
-2,135
-100% -$161K
QLD icon
2327
ProShares Ultra QQQ
QLD
$12.1B
$105 ﹤0.01%
+16
New +$433
PSK icon
2328
State Street SPDR ICE Preferred Securities ETF
PSK
$691M
$74 ﹤0.01%
2
-1,690
-100% -$56.6K
EWH icon
2329
iShares MSCI Hong Kong ETF
EWH
$1.23B
$57 ﹤0.01%
2
-301,357
-100% -$6.05M
THD icon
2330
iShares MSCI Thailand ETF
THD
$362M
$29 ﹤0.01%
+1
New +$70
HYLS icon
2331
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.6B
$23 ﹤0.01%
1
-2,699
-100% -$107K
ABBV icon
2332
CALL
AbbVie
ABBV
$470B
-50,000
Closed -$7.97M
ABBV icon
2333
PUT
AbbVie
ABBV
$470B
-50,000
Closed -$7.97M
ABCL icon
2334
AbCellera Biologics
ABCL
$1.53B
-95,621
Closed -$721K
ABOS icon
2335
Acumen Pharmaceuticals
ABOS
$154M
-44,385
Closed -$180K
ABR icon
2336
Arbor Realty Trust
ABR
$985M
-340,920
Closed -$3.92M
ABT icon
2337
CALL
Abbott
ABT
$190B
-90,000
Closed -$9.11M
ACDC icon
2338
ProFrac Holding
ACDC
$664M
-48,546
Closed -$615K
ACET icon
2339
Adicet Bio
ACET
$75.1M
-843
Closed -$77.7K
ACI icon
2340
Albertsons Companies
ACI
$5.59B
-1,976,204
Closed -$41.1M
ACM icon
2341
Aecom
ACM
$9.3B
-204,268
Closed -$17.2M
ACRE
2342
Ares Commercial Real Estate
ACRE
$259M
-19,517
Closed -$177K
ACTG icon
2343
Acacia Research
ACTG
$454M
-37,034
Closed -$143K
ACWX icon
2344
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
-1,956
Closed -$95.4K
ADEA icon
2345
Adeia
ADEA
$2.64B
-26,101
Closed -$231K
AEG icon
2346
Aegon
AEG
$13.5B
-1,132,644
Closed -$4.87M
AESI icon
2347
Atlas Energy Solutions
AESI
$1.32B
-18,966
Closed -$323K
AGGY icon
2348
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$924M
-2,018
Closed -$88.2K
AGNC icon
2349
AGNC Investment
AGNC
$12.6B
-258,998
Closed -$2.61M
AGO icon
2350
Assured Guaranty
AGO
$3.81B
-137,953
Closed -$6.93M

Similar funds

Qube Research & Technologies (QRT)'s Q2 2023 Portfolio in Review

As of Q2 2023, Qube Research & Technologies (QRT) held 3,226 positions worth $27.5B, up 18% from $23.2B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Qube Research & Technologies (QRT) deployed $26B of net new capital in Q2 2023, opening 745 new positions and adding to 868 existing holdings. Its largest new stake was Microsoft: 704,526 shares worth $240M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Cigna, an estimated $151M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2023 buy was Microsoft: 704,526 shares worth $240M.
  • Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2023, an estimated $192M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2023 reduction was Cigna, cutting an estimated $151M.
  • Qube Research & Technologies (QRT) fully exited ConocoPhillips in Q2 2023, selling an estimated $142M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 8.1% of its $27.5B portfolio in Q2 2023.
  • Qube Research & Technologies (QRT) opened 745 new positions and closed 894 in Q2 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 18% quarter-over-quarter to $27.5B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.